METROPOLIS - Technical Analysis with Chart Patterns & Indicators
Back to ListTechnical Rating: 3.5
| Stock Code | METROPOLIS | Market Cap | 9,879 Cr. | Current Price | 476 ₹ | High / Low | 566 ₹ |
| Stock P/E | 68.6 | Book Value | 64.0 ₹ | Dividend Yield | 0.21 % | ROCE | 13.4 % |
| ROE | 10.5 % | Face Value | 2.00 ₹ | DMA 50 | 466 ₹ | DMA 200 | 474 ₹ |
| Chg in FII Hold | -1.25 % | Chg in DII Hold | 1.07 % | PAT Qtr | 38.0 Cr. | PAT Prev Qtr | 46.6 Cr. |
| RSI | 56.5 | MACD | 6.27 | Volume | 88,177 | Avg Vol 1Wk | 92,508 |
| Low price | 397 ₹ | High price | 566 ₹ | PEG Ratio | -4.90 | Debt to equity | 0.11 |
| 52w Index | 47.1 % | Qtr Profit Var | 38.9 % | EPS | 6.66 ₹ | Industry PE | 34.6 |
📊 Metropolis Healthcare (METROPOLIS) is trading slightly above its 50 DMA (₹466) and 200 DMA (₹474), showing short-term support but limited strength. RSI at 56.5 reflects neutral-to-mild bullish momentum, while MACD (6.27) indicates positive divergence. Bollinger Bands suggest consolidation with no clear breakout. Current volume (88k) is slightly below the 1-week average (92k), signaling reduced participation.
💡 Optimal Entry: ₹460–₹470 (near DMA support)
🚪 Exit if Holding: Profit-taking zone around ₹540–₹560; Stop-loss below ₹455
📈 Trend Status: Consolidating with mild bullish bias
✅ Positive
- Trading above both 50 DMA and 200 DMA
- Quarterly PAT growth YoY (+38.9%)
- DII holdings increased (+1.07%)
- EPS at ₹6.66 supports earnings visibility
- Low debt-to-equity ratio (0.11)
⚠️ Limitation
- High valuation (P/E 68.6 vs industry 34.6)
- Weak ROE (10.5%) and ROCE (13.4%)
- PEG ratio negative (-4.90), indicating poor growth-adjusted valuation
- Sequential decline in PAT (₹46.6 Cr → ₹38.0 Cr)
- FII holdings decreased (-1.25%)
📉 Company Negative News
- Sequential profit decline despite YoY growth
- Valuation concerns with stretched multiples
- Reduced foreign institutional participation
📈 Company Positive News
- Strong YoY profit growth (+38.9%)
- DII inflows indicate domestic investor confidence
- Debt-light balance sheet ensures financial stability
🏭 Industry
- Diagnostics sector average PE at 34.6, Metropolis trades at a premium (68.6)
- Sector outlook stable with consistent demand but valuation pressures
🔎 Conclusion
Metropolis Healthcare is consolidating near support levels with mild bullish signals. Entry around ₹460–₹470 offers a controlled risk setup, while exits around ₹540–₹560 are advisable. Strong YoY growth and DII support are positives, but stretched valuations and weak efficiency metrics limit long-term attractiveness. Best suited for cautious swing trades with strict stop-loss discipline.